Oxford Medical Products raises €1.3 million for its safe weight loss tech, led by Ada Ventures

Oxford Medical Products (OMP) has secured €1.3 million in seed funding led by Ada Ventures and Selvedge Venture, along with angel investors. The funding will support the development of Sirona, a safe and affordable weight loss capsule that expands in the stomach to reduce hunger and promote weight loss. Sirona aims to provide a cost-effective alternative to surgical weight loss solutions, addressing the global obesity epidemic. OMP is currently conducting pre-clinical testing with human studies scheduled for 2022, aiming for a commercial launch in 2024.

Oxford Medical Products Raises €1.3 Million for Safe and Affordable Weight Loss Capsule

Oxford Medical Products (OMP) is a UK-based company developing a safe and affordable weight loss capsule, Sirona, which uses the same mechanism of action as a gastric balloon but can be taken at home. The capsule is a self-expanding hydrogel that expands in the stomach, reducing hunger and leading to significant weight loss. OMP aims to provide a cost-effective and accessible solution for weight loss, addressing the global issue of obesity and its associated health risks.

A UK-based company developing a safe and affordable weight loss capsule, Sirona, that expands in the stomach to reduce hunger and promote weight loss.

4 years ago

Oxford Medical Products Raises €1.3 Million for Safe and Affordable Weight Loss Capsule

ProblemTechnology

Solution

Covered on